Annual Drug Patent Expirations for XPHOZAH
Xphozah is a drug marketed by Ardelyx Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has seventy-six patent family members in twenty-eight countries.
The generic ingredient in XPHOZAH is tenapanor hydrochloride. One supplier is listed for this compound. Additional details are available on the tenapanor hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
